We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Asks Ariad to Halt U.S. Sales of Iclusig
FDA Asks Ariad to Halt U.S. Sales of Iclusig
November 1, 2013
Two weeks after the FDA issued a safety alert for Ariad Pharmaceuticals’ sole product Iclusig, the agency has asked the drugmaker to temporarily halt U.S. sales of the leukemia drug.